IP Library › Patent Application 14625922
Patent Application
App. No. 14/625,922

TRANSGENIC PLANTS EXPRESSING COBALAMIN BINDING PROTEINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/625,922
Abstract

The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.

Claims (14)

1 . A composition, the composition comprising intrinsic factor with plant specific glycosylation on the intrinsic factor, wherein all of the intrinsic factor in the composition is in the apo form.

2 . The composition of claim 1 , further comprising one or more pharmaceutically acceptable diluents, excipients, and/or carriers.

3 . The composition of claim 1 , wherein the composition is suitable for oral use.

4 . A composition, the composition comprising intrinsic factor, wherein all of the intrinsic factor in the composition is in the apo form within a plant cell.

5 . The composition of claim 4 , wherein the intrinsic factor is capable of binding cobalamin or an analog thereof.

6 . The composition of claim 5 , wherein the intrinsic factor has the capacity to bind to the cubilin receptor in vivo.

7 . The composition of claim 4 , further comprising one or more pharmaceutically acceptable diluents, excipients, and/or carriers.

8 . The composition of claim 4 , wherein the composition is suitable for oral use.

9 . A composition, the composition comprising intrinsic factor and a plant specific carbohydrate chain on the intrinsic factor, wherein all of the intrinsic factor is in the apo form.

10 . The composition of claim 9 , further comprising one or more pharmaceutically acceptable diluents, excipients, and/or carriers.

11 . The composition of claim 9 , wherein the composition is suitable for oral use.

12 . A method of producing functional recombinant intrinsic factor, the method comprising expressing intrinsic factor in a plant, wherein the intrinsic factor binds vitamin B12.

13 . The method of claim 12 , wherein the plant is “Generally Recognized As Safe” (GRAS).

14 . The method of claim 12 , wherein the intrinsic factor, when bound to B12, is capable of binding cubilin.